SHARPIN and synovial sarcoma: Furthermore, an analysis of synovial sarcoma samples from patients treated in our institute revealed that SHARPIN mRNA expression was significantly associated with shorter PFS (p < 0.005) but was not associated with OS (Figure 3H and Figure S8).